MedTrace Logo

Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia

NCT02326259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2022-08-12

No results posted yet for this study

Summary

The investigators are doing this research for two reasons. The first is to see how the retina (back of your eye) changes when your blood sugar is treated with medication for the first time. This will help us better understand the progression of a condition known as Diabetic Retinopathy. The second reason is to provide diabetic blood samples, which will possibly help identify biomarkers for diabetic retinopathy. Biomarkers are things that indicate the presence of a specific condition, and indicate a higher likelihood of developing that condition.

Conditions

Interventions

OTHER

Initiation of treatment of diabetes

Treatment of diabetes according to the standard of care.

Sponsors & Collaborators

  • Temple University

    lead OTHER

Principal Investigators

  • William J Foster, MD, PhD · Temple University

  • Ajay D Rao, MD, MMSc, FACP · Temple University

  • Raul A DeLa Cadena, MD · Temple University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02326259 on ClinicalTrials.gov